PRE 14C

OXIS INFORMATION STATEMENT 01-20-2011

Company: GT Biopharma, Inc.
Filed: January 7, 2011
Period of Report: January 20, 2011
Accession Number: 0000109657-11-000003

View Document ↗ View on SEC.gov ↗